Extracellular nicotinamide phosphoribosyltransferase (NAMPT/visfatin) inhibits insulin-like growth factor-1 signaling and proteoglycan synthesis in human articular chondrocytes.

Yammani RR, Loeser RF. Extracellular nicotinamide phosphoribosyltransferase (NAMPT/visfatin) inhibits insulin-like growth factor-1 signaling and proteoglycan synthesis in human articular chondrocytes. Arthritis Res Ther. 2012 Jan 30; 14(1):R23.

View in: PubMed

subject areas

Adipokines
Butadienes
Cartilage, Articular
Cells, Cultured
Chondrocytes
Collagen Type II
Enzyme Inhibitors
Extracellular Signal-Regulated MAP Kinases
Gene Expression
Humans
Immunoblotting
Insulin Receptor Substrate Proteins
Insulin-Like Growth Factor I
MAP Kinase Signaling System
Nicotinamide Phosphoribosyltransferase
Nitriles
Phosphorylation
Proteoglycans
Proto-Oncogene Proteins c-akt
Reverse Transcriptase Polymerase Chain Reaction
Signal Transduction

authors with profiles

Raghunatha Yammani PhD